Search

Search Constraints

You searched for: Author/Creator Raskob, Gary E.

Search Results

1. Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials. Issue 19 (7th April 2022)

2. Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population. (7th August 2022)

5. Global public awareness about atrial fibrillation. Issue 1 (25th October 2017)

6. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Issue 162 (February 2018)

7. Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. (19th November 2019)

8. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis. (22nd August 2021)

9. Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. (12th September 2021)

10. Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. (October 2021)